These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31043782)

  • 1. A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy.
    Chen D; Bian H; Zhang L
    Neuropsychiatr Dis Treat; 2019; 15():905-917. PubMed ID: 31043782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.
    Mbizvo GK; Dixon P; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001901. PubMed ID: 22972056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam add-on for drug-resistant focal epilepsy.
    Mbizvo GK; Chandrasekar B; Nevitt SJ; Dixon P; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD001901. PubMed ID: 35658745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD005612. PubMed ID: 35349176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide add-on therapy for focal epilepsy.
    Babar RK; Bresnahan R; Gillespie CS; Michael BD
    Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Ramaratnam S; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001909. PubMed ID: 32196639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011772. PubMed ID: 29691835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD011501. PubMed ID: 35285519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for seizures in catamenial (menstrual-related) epilepsy.
    Maguire MJ; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013225. PubMed ID: 34528245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carisbamate add-on therapy for drug-resistant focal epilepsy.
    Lu C; Zheng J; Cao Y; Bresnahan R; Martin-McGill KJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012121. PubMed ID: 34870321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
    Zhang L; Wang J; Wang C
    Acta Neurol Scand; 2021 Jul; 144(1):58-66. PubMed ID: 33788253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R; Atim-Oluk M; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012433. PubMed ID: 32129501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011501. PubMed ID: 30920649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy.
    Zhang L; Wang C; Li W
    Neuropsychiatr Dis Treat; 2018; 14():769-779. PubMed ID: 29559784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide add-on therapy for focal epilepsy.
    Brigo F; Lattanzi S; Igwe SC; Behzadifar M; Bragazzi NL
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001416. PubMed ID: 30335200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes.
    Tan HJ; Singh J; Gupta R; de Goede C
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006779. PubMed ID: 25190506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.